Professor of Medication and Pediatrics.

Asthmatx presents 2-12 months results from Air flow2 Trial of bronchial thermoplasty in serious asthma Boston Scientific Company today announced that its recently acquired subsidiary, Asthmatx, Inc http://www.silagratablets.net/reviews ., presented two-year outcomes from the Asthma Intervention Study 2 Trial demonstrating the long-term safety and efficiency of bronchial thermoplasty in adult individuals with severe asthma.D., Professor of Medication and Pediatrics, Washington University College of Medication and Principal Investigator of the AIR2 Trial, at the CHEST 2010 conference of the American University of Chest Doctors in Vancouver.